An Evaluation of the Safety of CSF-1 in Presbyopic Subjects
Public ClinicalTrials.gov record NCT05393895. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Masked, Vehicle-Controlled, Evaluation of the Safety of CSF-1 in Presbyopic Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, double-masked, vehicle-controlled study. The purpose of the study is to evaluate the safety of CSF-1 compared with vehicle in presbyopic subjects. Subjects will be treated for at least 6 weeks.
Study identification
- NCT ID
- NCT05393895
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 178 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 22, 2022 (Actual)
- Primary completion
- Dec 1, 2022 (Actual)
- Completion
- Dec 1, 2022 (Actual)
- Last update posted
- Jun 11, 2025
2022
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Orasis Investigative Site | Newport Beach | California | 92663 | — |
| Orasis Investigative Site | Petaluma | California | 94954 | — |
| Orasis Investigative Site | Colorado Springs | Colorado | 80907 | — |
| Orasis Investigative Site | Danbury | Connecticut | 06810 | — |
| Orasis Investigative Site | Rock Island | Illinois | 61201 | — |
| Orasis Investigative Site | Overland Park | Kansas | 66210 | — |
| Orasis Investigative Site | Elizabeth City | North Carolina | 27909 | — |
| Orasis Investigative Site | Fargo | North Dakota | 58103 | — |
| Orasis Investigative Site | Cranberry Township | Pennsylvania | 16066 | — |
| Orasis Investigative Site | Kingston | Pennsylvania | 18704 | — |
| Orasis Investigative Site | Memphis | Tennessee | 38119 | — |
| Orasis Investigative Site | Cedar Park | Texas | 78613 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05393895, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 11, 2025 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05393895 live on ClinicalTrials.gov.